Maletzke S, Salimi A, Vieri M, Schroeder KM, et al. Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia. PLoS One 2022;17:e0268352.
PMID: 36194587